ArticleJournal of cancer research and clinical oncology2024

First-line hepatic arterial infusion chemotherapy plus lenvatinib and PD-(L)1 inhibitors versus systemic chemotherapy alone or with PD-(L)1 inhibitors in unresectable intrahepatic cholangiocarcinoma.

Yan-Song Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.